REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 84 filers reported holding REGULUS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $116,000 | -69.9% | 585,828 | +0.1% | 0.00% | – |
| Q2 2018 | $386,000 | -31.1% | 585,357 | -25.0% | 0.00% | – |
| Q1 2018 | $560,000 | -34.3% | 780,792 | -4.5% | 0.00% | – |
| Q4 2017 | $852,000 | -15.9% | 818,004 | +1.1% | 0.00% | – |
| Q3 2017 | $1,013,000 | +94.1% | 809,320 | +52.7% | 0.00% | – |
| Q2 2017 | $522,000 | -85.1% | 529,947 | -75.1% | 0.00% | – |
| Q1 2017 | $3,507,000 | +58350.0% | 2,124,712 | +79091.7% | 0.00% | – |
| Q4 2016 | $6,000 | -40.0% | 2,683 | -9.3% | 0.00% | – |
| Q3 2016 | $10,000 | +11.1% | 2,959 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | -35.7% | 2,959 | +46.3% | 0.00% | – |
| Q1 2016 | $14,000 | -57.6% | 2,022 | -47.5% | 0.00% | – |
| Q4 2015 | $33,000 | +1550.0% | 3,853 | +1033.2% | 0.00% | – |
| Q3 2015 | $2,000 | -50.0% | 340 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 340 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | +20.0% | 340 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | – | 340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |